Kailash Chauhan, Author at Legal Desire Media and Insights https://legaldesire.com/author/kailash-chuhan/ Latest Legal Industry News and Insights Fri, 09 Jul 2021 05:26:46 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://legaldesire.com/wp-content/uploads/2018/11/cropped-cropped-cropped-favicon-1-32x32.jpg Kailash Chauhan, Author at Legal Desire Media and Insights https://legaldesire.com/author/kailash-chuhan/ 32 32 Covid-19 Vaccine: With Or Without IP? https://legaldesire.com/covid-19-vaccine-with-or-without-ip/ https://legaldesire.com/covid-19-vaccine-with-or-without-ip/#respond Fri, 09 Jul 2021 05:26:46 +0000 https://legaldesire.com/?p=54784 As some of the Pharmaceutical companies are about to put their COVID-19 vaccine in the market the debates of the waiving of IP rights have been started all over the world. The proposal for the same was submitted before TRIPS Council on October 2, 2020, jointly by Bharat and South Africa, and was supported by […]

The post Covid-19 Vaccine: With Or Without IP? appeared first on Legal Desire Media and Insights.

]]>
As some of the Pharmaceutical companies are about to put their COVID-19 vaccine in the market the debates of the waiving of IP rights have been started all over the world. The proposal for the same was submitted before TRIPS Council on October 2, 2020, jointly by Bharat and South Africa, and was supported by around 100 countries including China. It was opposed by high-income nations like U.K, U.S. Canada, Norway, Australia, and Japan.[i] The opposition parties also argued that provisions like compulsory licensing on pharmaceutical drugs already make the laws flexible enough to make it available to the whole world. The supporting parties argued that the procedure to get the compulsory license is very complicated.

 

Consequences of a vaccine without IP rights

IP is an enabler and without IP and its incentives, the world not is able to see the COVID-19 vaccine in such a large number and in such a small period of time. It is IP that encourages the pharmaceutical industry to invest in R&D related to the COVID-19 virus.        

Roche Group’s CEO Schwan who is also IFPMA Vice-President said that selling such an expensive technology without IP will not give much profit and will not sustainable in the long-term.[ii] After the landing of the vaccine in the market, there is a need to provide the vaccine in a large number, through cooperation with other producers and sharing IP related to vaccine and without the IP it will not be possible.

 

History of waiver of IP in case of drugs

In the past, many countries have tried to dilute the IP right of some drugs related to some serious diseases. In Many cases, the countries were gone through legal battles against giant pharmaceutical companies. In the case of Novartis Ag vs Union Of India & Ors, it took around 8 years to protect section 3(d) of the Indian Patent Act, which was challenged by the Company Novartis to monopolize the drug Glivec, a drug that treats Leukemia. It was April 1, 2013, when the Supreme Court rejected the argument of Novartis to struck down section 3(d) as it is unconstitutional. Novartis tried to patent the drug whose patent is about to end in another chemical form (Crystalline form) whose patent was about to end. And such patents are restricted under section 3(d) of the Act.

During 1996 a new drug of AIDS treatment was dropped in the African market whose cost was around $10000 for a year, which was too high to afford.[iii] It took almost 10 years to break the monopoly of the company by the governments and to bring down the cost of the drug. As the death rate was at its peak during this period a lot of deaths were happened just because of the high rate of the drug.

There is more likely that in the case of COVID-19 vaccine, to make revenue the companies may try to monopolize the market and it would take a lot of time to make the drug available to the poor Nations.

According to the vaccine producing capacity ( for the year 2021) of the companies, 82 percent of the vaccine in the case of Moderna and 82 percent in the case of Pfizer have been already sold to the rich countries like U.S., E.U., Japan, and Canada.[iv] Canada has pre-ordered vaccines in such a large number that it is equal to 10 doses per capita. It is totally up to the opposing countries to pressurize their companies to give up their IP as in many cases the governments have provided money from the public fund for the development of a vaccine. In the case of Astrazen, a sum of $2 billion and $2.5 billion in the case of Moderna was provided by US govt. German Government also provided $455 million to Pfizer for vaccine production.

 

What law says?

Article 31 of TRIPS allows the state party to use the patented drug without authorization in case of extreme urgency or national emergency shows that the Intention of the TRIPS agreement is to protect the right of the producers but in case of urgency like COVID-19 such right can be waived off by the state governments. COVID-19 is an extraordinary situation and almost all the countries have been affected by it.[v]

 

As the right to health is a fundamental right under Article 25(1) of the Universal Declaration of Human Rights (UDHR), Article 2(1) International Covenant on Economic, Social, and Cultural Rights (ICESCR), and under Article 6 (1) of International Covenant of Civil and Political Rights (ICCPR), these provisions make an obligation on the states to provide access to the drug to its citizens, which would be possible only after lowering the rates of the vaccine.[vi] Paragraph 4 of the Doha Declaration on the TRIPS Agreement and Public Health, 200,  says that the TRIPS agreement does not hinder the state to take steps to promote public health. Goal 3 of the Sustainable Development Goals (SDG) adopted in 2015 commits to ensuring the healthy life and promotes well beings. All these international laws promote the waiving of the IP rights from the essential life-saving drugs as without which these goals are hard to achieve.

 

The way ahead

While taking any step on this matter the WTO should also take care of the arguments made by the opposing parties that if Patent is waived off the big pharmaceutical companies would not further invest in the research because there would be no returns after the product is ready which would halt the progress of vaccine production.

Going through the procedure to invoke these provisions by individual countries would take a lot of time and by that time there would be a number of deaths and other economic losses to the countries. WTO should take appropriate steps to give access to the COVID-19 vaccine equally to all the countries.

References:

[i]https://timesofindia.indiatimes.com/world/rest-of-world/wto-to-discuss-india-backed-ipr-waiver-on-covid-19-drugs-today/articleshow/79653777.cms
[ii]https://www.thehindubusinessline.com/news/national/medical-tech-to-tackle-covid-19-ip-waiver-will-send-bad-signal-to-private-sector/article33291702.ece

[iii]https://theejbm.wordpress.com/2013/10/01/the-untold-aids-story-how-access-to-antiretroviral-drugs-was-obstructed-in-africa/
[iv]https://www.business-standard.com/article/current-affairs/suspending-ip-rights-is-the-way-to-go-if-world-wants-covid-19-vaccine-fast-120120800204_1.html
[v]  https://www.wto.org/english/docs_e/legal_e/27-trips_04c_e.htm
[vi]  https://www.hhrguide.org/2017/06/09/access-to-medicines-and-human-rights/

The post Covid-19 Vaccine: With Or Without IP? appeared first on Legal Desire Media and Insights.

]]>
https://legaldesire.com/covid-19-vaccine-with-or-without-ip/feed/ 0
Jio-Facebook Deal in the era of digital India: Concerns of privacy and data protection https://legaldesire.com/jio-facebook-deal-in-the-era-of-digital-india-concerns-of-privacy-and-data-protection/ https://legaldesire.com/jio-facebook-deal-in-the-era-of-digital-india-concerns-of-privacy-and-data-protection/#respond Sat, 26 Dec 2020 05:26:24 +0000 https://legaldesire.com/?p=48538 Technology development took a robust growth especially after the 1990s. In the field of Information technology, a lot of R&D and investment took place. With the development of and reach of IT in human life made concern for the data protection and privacy of the citizens. Under Article 21 of the constitutional right to privacy […]

The post Jio-Facebook Deal in the era of digital India: Concerns of privacy and data protection appeared first on Legal Desire Media and Insights.

]]>
Technology development took a robust growth especially after the 1990s. In the field of Information technology, a lot of R&D and investment took place. With the development of and reach of IT in human life made concern for the data protection and privacy of the citizens. Under Article 21 of the constitutional right to privacy is a fundamental right of her citizen. Privacy is defined as

         “The right to privacy is protected as an intrinsic part of the right to life and personal liberty under Article 21 and as a part of the freedoms guaranteed by Part III of the Constitution.”[1]

Recently Facebook had a deal with Jio in which the former invested in Jio, a subsidiary of Reliance Industry Ltd. which rose concerns on the privacy of the citizens of India by Facebook’s buying of  9.99% stack in Jio of worth 43,574.[2]

The technology involved in the deal

The use of Artificial intelligence in such platforms collects a lot of data related to the activities of the users. Jio has 387.5 million subscribers in India who are using various Jio services as:

Jio T.V for news and entertainment,

A JIo for online shopping,

Jio savan for music listening,

Jio pay for online payments,

Jio fiber for internet broadband services.

Recently Jio has also launched Jio meet for online video group callings. Facebook has 280 million users in India. Facebook-owned Whatsapp and Instagram have 400 million and 120 million respectively. The partnership of these two Giants has raised serious concerns of data protection and competition law In India. After jio- facebook deal Jio decided to launch the online retail services on the Facebook-owned WhatsApp.  Services have been started in some cities soon after the deal.[3] As use and sharing of meta-data are allowed in India, the companies can use this data for analysis to take advantage in their businesses.  With the help of analytics and data Interpretation of such a large and variety of meta-data, a lot of other information can be drawn which would fall under the definition of privacy.

A fine example of using and manipulating general data is the Cambridge Analytica case, in which the company simply gathered simple data to gather information about the psychology of the person, and then by analysis of this data the opinions of the person can be manipulated.[4]  N According to some experts Cambridge Analytica also worked in India in the same way as in the USA but it was never got investigated in India.[5] This shows the concerns related to data protection and privacy in India and the attitude of the Government towards it. The lack of awareness about data protection and privacy in society is also a big issue. With the use of Artificial Intelligence (AI) and machine learning (ML) a lot of information can be dawned from this meta-data.

Will Jio share data to Facebook?

The Jio’s privacy policy says that the company limits the data sharing (PAN, address, photograph, contact number, passport etc)  in certain circumstances to a scenario like a merger and acquisition that affects the company and the partners. The exception of sharing of data with “partners” includes consultant, contractors, vendors, companies, and affiliates who provides a host of services including customer service, website hosting, It services data analysis, infrastructure hosting and similar services.[6] The Jio-Facebook partnership can put Facebook in the category of a partner, which would allow Jio to share the data of its subscribers.

Need of the data protection laws

With the reach and use of Technology in the lives of people especially in the IT and communication sector have deepened the need for laws to regulate the data collected by the service provides. The government’s policies like digital India and promotions of the use of technology in almost every sector in the country have increased the number of users.

We need a law which regulates and protects the data collected by the services providers. India needs a law like the General Data Protection Regulation (GDPR) which is a fine example of data protection. This law was enforced by European Union in January 2012 which is the core of Europe’s digital privacy legislation. The law makes sure that personal data should be collected legally and should be protected from misuse and exploitation.

This law applies to any organization which is an operation within the EU and any organization outside the EU but offering goods and services to the customer of businesses in the EU. This means every company providing services in EU have to need a GDPR compliance strategy.[7]

GDPR brings the right to be forgotten and right to know when the data is being compromised or hacked, the organization have to notify within the 72 hours of the breach. In case of non-compliance with the GDPR, there is a penalty of 10 million or 4 percent of companies annual global turnover. Even in case of mishandling of data in other ways put a penalty of 10 million Euros or 2 per cent of annual global turnover. The best thing about GDPR is that there is no ‘one size fits all’ approach to preparing for the laws but each business needs to know what they need to comply with the law. So this law would apply to everyone from a single person company to a MNC.

If India is supposed to have such a regulation the protection of data and privacy of citizens can be ensured. Although in 2019 Personal Data Protection Bill was introduced in parliament but still not been passed. The need for a strict regulation will be needed in the future as the government would be coming with more and more policies to digitize India and the threat to the data protection and privacy will increase. 

The technology growth is accelerating and new technologies will emerge which would need to control and regulate and we will need such laws. The technologies like Face reading apps and Deep fake already have put serious legal concerns. Under article 21 read with article 19 of the constitution makes privacy the most important right of the citizen of the country. So to protect these rights we need to regulate these technologies.

 

 

 

 

 


[1] https://www.eff.org/deeplinks/2017/08/indias-supreme-court-upholds-right-privacy-fundamental-right-and-its-about-time

[2] https://www.businesstoday.in/current/corporate/facebook-reliance-jio-deal-social-media-giant-pumps-in-rs-43574-crore-in-mukesh-ambani-telco-10-points/story/401654.html

[3] https://www.businessinsider.in/business/ecommerce/news/reliance-e-commerce-venture-jiomart-makes-a-silent-debut-calls-for-pre-registrations/articleshow/73046911.cms

[4] https://www.theguardian.com/news/2018/may/06/cambridge-analytica-how-turn-clicks-into-votes-christopher-wylie

[5] https://www.thehindubusinessline.com/info-tech/social-media/cambridge-analytica-worked-extensively-in-india-and-for-congress-says-whistleblower-tells-uk-parliamentary-panel/article23366308.ece

[6] https://www.businesstoday.in/current/corporate/justice-srikrishna-red-flags-reliance-jio-facebook-deal-on-data-privacy-lack-of-regulator/story/403571.html

[7] https://www.zdnet.com/article/gdpr-an-executive-guide-to-what-you-need-to-know/

The post Jio-Facebook Deal in the era of digital India: Concerns of privacy and data protection appeared first on Legal Desire Media and Insights.

]]>
https://legaldesire.com/jio-facebook-deal-in-the-era-of-digital-india-concerns-of-privacy-and-data-protection/feed/ 0